Relationship between reduced serum IGF-I levels and accumulation of visceral fat in Japanese men

被引:47
作者
Kunitomi, M
Wada, J
Takahashi, K
Tsuchiyama, Y
Mimura, Y
Hida, K
Miyatake, N
Fujii, M
Kira, S
Shikata, K
Makino, H
机构
[1] Okayama Univ, Sch Med, Dept Med 3, Okayama 7008558, Japan
[2] Okayama Univ, Fac Educ, Okayama, Japan
[3] Okayama So Inst Hlth, Okayama, Japan
[4] Okayama Univ, Sch Med, Dept Publ Hlth, Okayama 700, Japan
关键词
insulin-like growth factor-I (IGF-I); visceral fat; exercise;
D O I
10.1038/sj.ijo.0801899
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To investigate whether the changes in IGF-1 concentrations after weight reduction in Japanese overweight men are associated with changes in visceral and subcutaneous fat. DESIGN: Cross-sectional and longitudinal clinical intervention study with exercise education. SUBJECTS: One-hundred and twelve Japanese overweight men aged 30-59y (body mass index (BMI) 28.4+/-2.5 kg/m(2)) and 33 normal-weight men aged 30-39y (BMI 22.1+/-1.5 kg/m(2)) at baseline. From the participants, 56 randomly selected overweight men (BMI 28.8+/-2.8) were further enrolled into a 1 y exercise program. MEASUREMENTS: Fat distribution was evaluated by visceral fat M and subcutaneous fat (S) areas measured with computed tomography scanning at umbilical levels, metabolic parameters and hormones including insulin, leptin and IGF-1 at baseline and after 1 y. RESULTS: In 112 overweight subjects at baseline, insulin (10.5+/-5.0 muUl/ml) and leptin (6.4+/-3.7 ng/ml) significantly correlated with both V (r=0.260, P=0.0073; r=0.410, P<0.0001) and S areas (r=0.377, P<0.0001; r=0.613, P<0.0001), respectively. IGF-1 (156.8+/-48.7 muU/ml) significantly and negatively correlated with V area (r= -0.242, P=0.0125)and age (r= - 0.192, P=0.0480). In normal-weight men aged 30-39y (n=33) and age-matched subjects (n=30) selected from the 112 overweight men, the serum IGF-1 further tightly correlated with V area (r= - 0.467, P<0.0001). Visceral fat area and age were independently related to serum IGF-1 levels by multiple regression analysis. By intervention with exercise education, 56 overweight subjects showed an increase in daily steps (6224+/-2781 to 7898+/-4141 steps/day) and reduction of BMI (28.8+/-2.8 to 27.7+/-2.9). DeltaIGF-1 significantly correlated with DeltaV area (r= - 0.432, P = 0.0009) but not with DeltaS area or DeltaBMI. CONCLUSION: The present study indicated a negative correlation between IGF-1 levels and visceral fat at baseline as well as an association between the reduction in visceral fat and increase in IGF-1 levels after an exercise intervention.
引用
收藏
页码:361 / 369
页数:9
相关论文
共 39 条
  • [11] HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY
    GORDON, T
    CASTELLI, WP
    HJORTLAND, MC
    KANNEL, WB
    DAWBER, TR
    [J]. AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) : 707 - 714
  • [12] A prospective analysis of the HOMA model - The Mexico City Diabetes Study
    Haffner, SM
    Gonzalez, C
    Miettinen, H
    Kennedy, E
    Stern, MP
    [J]. DIABETES CARE, 1996, 19 (10) : 1138 - 1141
  • [13] THE DISTAL AXIS OF GROWTH-HORMONE (GH) IN NUTRITIONAL DISORDERS - GH-BINDING PROTEIN, INSULIN-LIKE GROWTH FACTOR-I (IGF-I), AND IGF-I RECEPTORS IN OBESITY AND ANOREXIA-NERVOSA
    HOCHBERG, Z
    HERTZ, P
    COLIN, V
    ISHSHALOM, S
    YESHURUN, D
    YOUDIM, MBH
    AMIT, T
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (01): : 106 - 112
  • [14] Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotropic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men
    Iranmanesh, A
    South, S
    Liem, AY
    Clemmons, D
    Thorner, MO
    Weltman, A
    Veldhuis, JD
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 139 (01) : 59 - 71
  • [15] Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure
    Johannsson, G
    Marin, P
    Lonn, L
    Ottosson, M
    Stenlof, K
    Bjorntorp, P
    Sjostrom, L
    Bengtsson, B
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (03) : 727 - 734
  • [16] REGIONAL OBESITY AND RISK OF CARDIOVASCULAR-DISEASE - THE FRAMINGHAM-STUDY
    KANNEL, WB
    CUPPLES, LA
    RAMASWAMI, R
    STOKES, J
    KREGER, BE
    HIGGINS, M
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1991, 44 (02) : 183 - 190
  • [17] Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects
    Lanzi, R
    Luzi, L
    Caumo, A
    Andreotti, AC
    Manzoni, MF
    Malighetti, ME
    Sereni, LP
    Pontiroli, AE
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (09): : 1152 - 1156
  • [18] REDUCED GROWTH-HORMONE RESPONSE TO GROWTH HORMONE-RELEASING HORMONE IN CHILDREN WITH SIMPLE OBESITY - EVIDENCE FOR SOMATOMEDIN-C MEDIATED INHIBITION
    LOCHE, S
    CAPPA, M
    BORRELLI, P
    FAEDDA, A
    CRINO, A
    CELLA, SG
    CORDA, R
    MULLER, EE
    PINTOR, C
    [J]. CLINICAL ENDOCRINOLOGY, 1987, 27 (02) : 145 - 153
  • [19] Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients
    Maccario, M
    Ramunni, J
    Oleandri, SE
    Procopio, M
    Grottoli, S
    Rossetto, R
    Savio, P
    Aimaretti, G
    Camanni, F
    Ghigo, E
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 1999, 23 (06) : 612 - 618
  • [20] MARIN P, 1993, INT J OBESITY, V17, P83